Enzyme-linked immunosorbent assay (ELISA) protocols for the detection of antibodies to Mycobacterium paratuberculosis have employed a variety of antigens. These include crude protoplasmic antigens from M. paratuberculosis strains 18, 3,4 
than 1 year. 4 Subtotal pericardectomy has been reported to be effective in resolving recurrent pericardial effusions and non-neoplastic mass lesions (cysts, abscesses, and granulomas). This procedure has been reported to be partially effective in treating accessible heart base tumors. 15 The cause of canine extraskeletal chondrosarcomas is not known. Sarcomas following ocular trauma have been reported in cats. 5 In humans, some extraskeletal osteosarcomas are associated with a history of trauma. 3 The dog in this case sustained a kick to the chest 2 months prior to presentation and pericardial trauma may have occurred. Extraskeletal chondrosarcomas may potentially arise from de novo neoplastic transformation of pluripotential mesenchymal cells or from malignant transformation of metaplastic chondroid tissue. 8 In this case, ante mortem diagnosis of a probable neoplastic mass was made by ultrasound examination and fine needle aspiration. Ultrasound examination is reported to be an effective method of diagnosis of canine intrapericardial mass lesions, but pericardial fluid cytology is less reliable in confirming the diagnosis. 4 The distinctive morphologic features of the tumor cells in the pericardial aspirate of this dog were critical in making an ante mortem diagnosis of malignancy.
latter is used in a Commonwealth Serum Laboratories (CSL) kit a also available in the USA. b Other antigens include ammonium sulfate protoplasmic peptide antigens of strain 18, 19, 21 which is also commercially available as paratuberculosis protoplasmic antigen (PPA-3) c for use in ELISA, a similarly prepared antigen from strain ATCC 19698, 19 antigens prepared from strain 18 by ion-exchange immunosorbent chromatography, 1 a 34-kD M. paratuberculosis-specific protein antigen, 7 and the polysaccharide lipoarabinomannan (LAM) antigen. 9, 15, 18 Subsequent to the development of the commercially available kit, the question arose as to whether antigens other than Figure 1 . Inhibition ELISA. ELISA activities are expressed as a percentage of uninhibited activity (OD 414 nm) on the Y-axis; the X-axis depicts increasing amounts of antigen concentrations used for absorption. The 4 graphs represent inhibition of M. paratuberculosis-infected cow no. 1 serum at 1:1,000 dilution. Empty circles, ELISA activity due to coated LAM (LAM activity); solid circles, ELISA due to coated PPA-3 (PPA-3 activity); and empty triangles, ELISA due to coated CSL antigen (CSL activity). the CSL antigen provided in the kit could work as well after preabsorption of sera with M. phlei. Both PPA-3 22 and LAM antigens, 16 when used in ELISA in conjunction with this preabsorption, behaved similarly to the CSL antigen in demonstrating improvements in test specificity for the serodiagnosis of bovine paratuberculosis. PPA-3-ELISA compared closely with the kit for a particular serum panel. 13 Equally important, and the subject of this brief investigation, would be a comparison of LAM antigen with either PPA-3 or CSL antigen, because LAM is a polysaccharide antigen and may therefore reveal distinctly different antibodies.
Inhibition ELISA studies were performed using sera from M. paratuberculosis cattle to probe the cross-reactivity between CSL, PPA-3, and LAM antigens. Following this, the LAM antigen was compared to the CSL kit antigen in ELI-SA after preabsorption of sera with solubilized M. phlei on a small number of sera from noninfected and infected cattle. LAM antigen was coated on plates in this laboratory, whereas plates coated with CSL antigen were available from the commercial kit.
For inhibition ELISA, 100 l of 1.0 g/ml LAM 17 or 5.0 g/ml PPA-3 antigens in 0.06 M sodium carbonate buffer (pH 9.6) were coated overnight at 25 C on polystrene plates. d As stated above, plates with coated CSL antigen were available from the commercial kit. Concurrently, sera from 2 M. paratuberculosis-infected cows were preincubated overnight at 25 C in the absence or presence of absorbing antigens at 0, 2, 4, 8, 10, 20, 50, and 100 g/ml for LAM; lipid-free arabinomannan from ultracentrifugal supernatants after phenol-water extraction (AM-1) or after alkaline extraction (AM-2); 17 PPA-3; glucan from M. paratuberculosis; 17 Salmonella typhimurium lipopolysaccharide (LPS); e or Escherichia coli LPS. f Whether in the absence or presence of the absorbing antigens, the serum diluent was 0.01 M sodium phosphate in saline (pH 7.2) containing 0.05% Tween 20 (PBS-T). The dilution in the absence of the absorbing antigens was such that the ELISA optical density (OD) values was approximately the same as that of the target serum (see below). This was 1:1,000 for cow no. 1 and 1:500 for cow no. 2.
The following day the plates were washed g with PBS-T (all washes were 3-fold). A cross quadrant placement of the preincubated sera was done to minimize between-well variation. 14 After an overnight incubation at 25 C and washing plates with PBS-T, 100 l of biotinylated protein G h was added to the wells. The plates were then incubated further for 2 hours, washed, and incubated with 100 l of horseradish peroxidase-labeled streptavidin i for another 2 hours. Both conjugates were diluted with PBS-T at 1:5,000. The plates underwent a final wash and 200 l of the substrate/chromogen containing 4.0 mM H 2 O 2 plus 1.0 mM ABTS (2,2Јazino-di-[3-ethylbenzthiazoline sulfonic acid]) in 0.05 M sodium citrate (pH 4.5) 20 was added. The plates were developed with shaking j and read at 414 nm k according to a targeting protocol. 20 According to this protocol, the reaction was not stopped but was read when the average OD value of a standard ''target'' serum (from an infected cow) reached 1.0, at which time the plate was read, thus reducing betweenplate variation.
The inhibition ELISA results for cow serum no. 1 depict-ed in Fig. 1 (top graph) revealed that a concentration of 100 g/ml LAM absorbed antibodies to yield approximately a residual LAM activity (activity after absorption due to coated LAM) that was 12% of the uninhibited activity (activity in the absence of any absorbing antigens). The same concentration of LAM antigen absorbed the antibodies of these same cows to yield a residual PPA-3 activity (coated PPA-3) of 53%, revealing less inhibition and suggesting that PPA-3 is a mixture of antigens exhibiting both LAM-like and other non-LAM antigenic activity. On the other hand, the ELISA activity due to coated CSL antigen (CSL antigen activity) appeared to be unaffected by absorption of sera with LAM antigen, suggesting that CSL and LAM antigens are distinctly different. Two lipid-free forms of arabinomannan, AM-1, coextracted with LAM by phenol-water extraction, and alkaline-extracted AM-2, inhibited LAM activity similarly to LAM ( Fig. 1 ; middle graphs). The inhibition study of CSL antigen activity by AM-1 and AM-2 was not done in order to conserve the precoated kit plates. The results for cow serum no. 2, not shown, were very similar.
In contrast to the partial inhibition of PPA-3 activity by LAM and arabinomannan antigens, both PPA-3 and LAM activities were inhibited to approximately the same basal values as above by PPA-3 antigen ( Fig. 1; bottom graph) , which may be expected if PPA-3 contains LAM-like activity. The fact that more PPA-3 is nevertheless required to maximally absorb serum antibodies to inhibit LAM activity than is required to inhibit the PPA-3 activity further supports the above suggestion that only part of it is LAM-like. CSL antigen activity was only weakly inhibited by PPA-3, suggesting that there is a only a small amount, if any, of the CSL antigen in PPA-3. It should be noted that studies using the CSL antigen as an inhibitory antigen were not done since this antigen was provided only on precoated plates.
Neither M. paratuberculosis glucan, Salmonella typhimurium LPS, nor E. coli LPS affected any of the ELISA activities (data not shown), indicating that the inhibitory activity of LAM and AM is not a nonspecific polysaccharideinduced effect.
Because CSL and LAM antigens appear to contain distinctively different epitopes, it was decided to conduct a preliminary trial to compare these antigens in ELISA after preabsorption in both cases with an M. phlei absorbent from the commercial kit. This was done on a small panel comprising 15 samples from M. paratuberculosis-infected cattle and 10 samples from certified paratuberculosis-free cattle purchased from the National Repository, University of Wisconsin, Madison, Wisconsin. Depending on the feasibility of this approach, this trial could be expanded to a study involving a larger number of animals, for which statistical analyses would be possible.
The ELISA protocols in this case involved stopping the reaction after development with 3,3Ј,5,5Ј-tetramethylbenzidine (TMB) substrate according to the kit protocol, rather than with the targeting protocol used above. Next, it was necessary to design the procedure such that the only variable between the 2 ELISA protocols was the coated antigen. Aside from this, both involved an initial preabsorption of sera with the same M. phlei kit reagent as stated above, the use of PBS-T for washes, and the same conjugate and substrate from other commercial sources, which were horseradish peroxidase goat anti-bovine IgG (HϩL) conjugate l and TMB substrate. m The procedure closely followed the same steps as those specified in the commercial kit. The sera were diluted 1:20 in the M. phlei-absorbing solution and incubated for 30 minutes. The absorbed sera were added to the CSLor LAM-antigen-coated plates and incubated for 30 minutes, the plates were washed (all washes were 3 times as above), and incubated for 30 minutes after the addition of 100 l conjugate. The plates were washed again and developed in the presence of 100 l TMB, and finally the reaction was stopped with the kit reagent. Because different antibody populations were being detected, the concentrations of the conjugate and substrate were adjusted for each ELISA to attain an equivalent OD value of approximately 1.0 at 450 nm within 20 minutes of development and after stopping the reaction. For the same reason, different serum controls were used for LAM activity, because a CSL antigen activity serum may be low in LAM activity and vice versa. For the ELISAs, due to coated CSL and LAM antigens, the conjugate was diluted 1:5,000 and 1:8,000 in PBS-T, respectively. For the CSL antigen activity the substrate was 4.0 mM H 2 O 2 plus 2.0 mM TMB in 0.05 M sodium citrate (pH 4.5). For the LAM activity the TMB concentration was 1.0 mM TMB. The cutoff for each ELISA to distinguish positive from negative results, based on the panel from the National Repository, was the lowest OD value to give the highest true results. This value was equal to the highest sum of true positives and true negatives or the highest sum of sensitivity and specificity. The results from duplicate analyses are summarized in Table 1 . Of 15 M. paratuberculosis-infected cattle, 13 were positive on detection of CSL antigen activity, 12 were positive on detection of LAM activity, and 11 were positive on both ELISA protocols.
In spite of criticisms of the lack of specificity for LAM antigen, a humoral response to this immunodominant antigen also occurs in other important mycobacterial diseases, such as bovine tuberculosis, thus meeting the requirement of a good screening antigen. 8 Furthermore, LAM is an important antigen in that it may play an important role in the pathogenesis of paratuberculosis by causing the release of inflammatory cytokines involved in granulomatous inflammation and cachexia. 2 The present comparative study extends one previous study that demonstrated that preabsorption with M. phlei can work with LAM antigen, in that it reduces the false positive rate. 16 Although the use of a different conjugate than that supplied in the kit, as well as other differences, may raise doubts concerning the quality of ELISA detection as specified by the kit, it should be noted first that the conjugate used here was also a horseradish peroxidase goat anti-bovine IgG as used in the kit, and second, that the CSL antigen activity shown in Table 1 showed the same true negatives and actually 2 more true positives than the CSL ELISA results provided along with the sera by the National Repository. Nevertheless, in the absence of a more thorough analysis, in cannot be unequivocally claimed that the kit CSL antigen plates performed according to kit specifications.
This close agreement between ELISA protocols using coated CSL and LAM antigens infers a development of populations of antibodies to both antigens. However, the disagreement occurring in 3 of 15 of the M. paratuberculosisinfected animals may signal a preferential response in some animals to a particular antigen. This is genuine in one animal showing a strong LAM activity but a negative CSL antigen response. This phenomenon may result in a greater detection of infected animals using a dual antigen assay, 12 and in fact, a parallel interpretation of the data in Table 1 revealed detection of 14 of 15 of the M. paratuberculosis-infected animals. Alternatively, this LAM activity, positive as well for the paratuberculosis-free animal, may reflect the known lack of specificity of LAM, and perhaps is revealing a humoral response to another mycobacterial species such as M. avium or a saprophytic species. This distinction would not have been possible, or as clear, from a comparison of PPA-3 activity to either CSL antigen activity or LAM activity, because PPA-3 likely shares antigens with both CSL and LAM antigens.
The success of ELISA using LAM in this protocol was a surprise when initially observed. 16 Because LAM is common to all mycobacteria, M. phlei should remove anti-LAM antibodies, thus decreasing LAM activity relative to the activity in the absence of M. phlei. It may be, however, that M. phlei removes virtually all of the anti-LAM antibody activity from noninfected animals and only a fraction of that from infected animals, resulting in a reduction in the false positive rate, as with the CSL antigen activity. Indeed, initial studies had demonstrated that sera with high antibody levels were affected less by preabsorption with M. phlei than sera with low levels. 22 Acknowledgements. The authors kindly acknowledge the cooperation of Dr. M. T. Collins of the University of Wisconsin, and to P. Martineau, G. Saumure, and Dr. J. Stevens of the Animal Disease Research Institute for production of M. paratuberculosis used to produce LAM antigen. Brucella suis is the causative agent of brucellosis in swine, rabbits, reindeer, and caribou. 1, 2, 6, 9, 17, 18 Brucella suis has also been reported to infect dogs, horses, humans, and cattle but has been considered a noncontagious disease in nonprimary hosts. 1 The number of B. suis isolates from bovine tissue and/or milk confirmed or identified at the National Veterinary Services Laboratories (NVSL) varied from 5 in 1986 to a high of 15 in 1991. Most of these isolates were from animals in the swamp areas of the southeastern United States, especially southern Florida. A large population of feral swine are located in the same area as the B. suis-infected cattle. Approximately 25% of the feral swine are seropositive for brucellosis. 20 Little information about the disease process produced by B. suis biovar 1 in cattle has been reported. 9, 17 The purpose of this study was to examine the bacterial, serological, and histological effects of B. suis in naturally infected cattle.
Sources and manufacturers
Six cows (1-6) naturally infected with B. suis biovar 1 and 1 calf (2A) from cow 2 were obtained from 4 southern Florida counties (Brevard, Hardee, Hendry, and Osceola). Two serologically negative, nonvaccinated cows (7 and 8) and a serologically negative bull (9) were included as control animals to monitor transmission. Six calves (2B, 3A, 4A, 5A, and 6A) were born to the infected cows in the study, and 4 calves (7A, 7B, 8A, and 8B) were born to the control cows during the study. All animals, including the calves, were kept together in an animal biosafety level 2 facility at the NVSL. After 2 years, tissue and serum samples were collected at necropsy from all the animals in the study except for the offspring of the 2 control cows, cultured for Brucella, and tested for Brucella antibodies.
Heparinized blood samples, vaginal swabs, and quarter milk samples were collected from the cattle biweekly and cultured for Brucella. 13 Serum samples and quarter milk samples were evaluated for the presence of Brucella anti-From the US Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, National Veterinary Services Laboratories, Ames, IA 50010.
Received for publication December 6, 1995. bodies. 3 Placentas were collected and cultured for Brucella at the time of parturition. The following tissues were collected from the cows at necropsy: lymph nodes (pharyngeal, prescapular, mammary or scrotal, parotid, mandibular, bronchial, internal and external iliac, mesenteric, lumbar, and hepatic), mammary gland, spleen, lung, uterus, ovary, kidney, liver, epididymis, and testicle. A portion of each tissue specimen was processed and inoculated on selective media for Brucella, and the remainder was placed in 10% neutral buffered formalin and routinely processed for histopathologic examination. Brucella isolates were identified by the approved methods. 4 Sera were tested for Brucella antibodies by the following tests: card, buffered acid plate antigen (BAPA), complement fixation (CF), mercaptoethanol (ME), standard plate agglutination (SPT), rivanol (RIV), standard tube agglutination (STT), concentration immunoassay (CI), a and particle concentration fluorescence immunoassay (PCFIA). a,3 Sera from the 6 infected cows and 6 of the 7 calves from infected dams were evaluated by the competitive ELISA (c-ELISA). b, 12 Quarter milk samples were tested for Brucella antibodies by the serial Brucella ring test (BRT). 3 Prior to parturition, B. suis biovar 1 was continuously isolated from the milk of all naturally infected cows, except cow 2, for up to 2 years. Isolation of B. suis biovar 1 from cow 2 was intermittent. Brucella suis biovar 1 was isolated from the milk of cow 1 continuously for 2 years and 7 months. With the exception of cows 2 and 5, isolations were made from 1 to several months following parturition. Brucella was not isolated from cows 2 and 5 following parturition. No Brucella was isolated from the vaginal swabs, blood, or placenta of any of the infected cows. Brucella suis biovar 1 was isolated from the mammary gland and the internal iliac lymph nodes of cow 1. Cow 6's calf died at birth due to dystocia, and cow 6 was euthanatized and necropsied 13 days later. Brucella suis biovar 1 was isolated from the mammary gland, the mammary lymph nodes, and the pharyngeal lymph nodes of cow 6. Brucella was not isolated from tissues obtained at necropsy of the 4 remaining natu-
